Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Entero Healthcare SolutionsNSE:ENTERO -2.60%44 Return-on-Tangible-Equity is 12.07% as of Mar. 2026, which is 1600% above its 10-year median of 0.71. GuruFocus rates NSE:ENTERO with a GF Score™ of 44/100. The stock has 2 warning signs investors should review. Among 111 Medical Distribution companies, Entero Healthcare Solutions ranks better than 55.86% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Entero Healthcare Solutions's annualized net income for the quarter that ended in Mar. 2026 was ₹1,120 Mil. Entero Healthcare Solutions's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹9,285 Mil. Therefore, Entero Healthcare Solutions's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 12.07%.
The historical rank and industry rank for Entero Healthcare Solutions's Return-on-Tangible-Equity or its related term are showing as below:
NSE:ENTERO'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -7.5 Med: 0.71 Max: 10.34
Current: 9.79
During the past 6 years, Entero Healthcare Solutions's highest Return-on-Tangible-Equity was 10.34%. The lowest was -7.50%. And the median was 0.71%.
NSE:ENTERO's Return-on-Tangible-Equity is ranked better than 55.86% of 111
companies
in the Medical Distribution industry
Industry Median: 8.81
vs NSE:ENTERO: 9.79
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Entero Healthcare Solutions Return-on-Tangible-Equity Related Terms
Entero Healthcare Solutions Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ENTERO vs MCK, CAH, COR: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Entero Healthcare Solutions's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Entero Healthcare Solutions Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Entero Healthcare Solutions's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Entero Healthcare Solutions's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 12.07% mean?
Entero Healthcare Solutions (NSE:ENTERO) has a Return-on-Tangible-Equity of 12.07% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Entero Healthcare Solutions and its competitors. This is 1600% above median its historical median of 0.71. According to the industry distribution chart, Entero Healthcare Solutions ranks #49 out of 111 companies in the Medical Distribution industry, placing it in the top 44.1%.
Is Entero Healthcare Solutions' Return-on-Tangible-Equity too high?
Entero Healthcare Solutions' current Return-on-Tangible-Equity of 12.07% is 1600% above median its 10-year median of 0.71. The Medical Distribution industry median Return-on-Tangible-Equity is 8.81. Entero Healthcare Solutions' value of 12.07% is 37% above this industry median. Based on the distribution chart, Entero Healthcare Solutions ranks #49 out of 111 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Entero Healthcare Solutions has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Entero Healthcare Solutions' Return-on-Tangible-Equity compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Entero Healthcare Solutions ranks #49 out of 111 companies for Return-on-Tangible-Equity. This puts Entero Healthcare Solutions in the upper half of its industry. The industry median Return-on-Tangible-Equity is 8.81. Entero Healthcare Solutions' value of 12.07% is 37% above this benchmark. While the company's 10-year median is 0.71 vs. the industry median of 8.81, Entero Healthcare Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.81, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Entero Healthcare Solutions's current Return-on-Tangible-Equity of 12.07% is 37% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Entero Healthcare Solutions and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Entero Healthcare Solutions's current Return-on-Tangible-Equity is 12.07%, which is 1600% above median its own 10-year median of 0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Entero Healthcare Solutions stock overvalued right now?
Entero Healthcare Solutions (NSE:ENTERO) has a current Return-on-Tangible-Equity of 12.07%. The current Return-on-Tangible-Equity is 12.07%, which is 1600% above median its 10-year median of 0.71 and 37% above the Medical Distribution industry median of 8.81. Entero Healthcare Solutions' overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Entero Healthcare Solutions (NSE:ENTERO), the current Return-on-Tangible-Equity is 12.07% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Entero Healthcare Solutions Ltd is a healthcare products distributor in India. It is involved in the business of distribution and marketing of pharmaceutical and surgical products and allied services. Geographically, the company derives a majority of its revenue from the domestic market.
44GF Score
Get the complete analysis for NSE:ENTERO
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ENTERO has been successfully added to your 
